Search Results - Ronald Peck
- Showing 1 - 7 results of 7
-
1
-
2
Efficacy and Safety of Ixabepilone (BMS-247550) in a Phase II Study of Patients With Advanced Breast Cancer Resistant to an Anthracycline, a Taxane, and Capecitabine by Edith A. Perez, Guillermo Lerzo, Xavier Pivot, Eva Thomas, Linda T. Vahdat, Linda D. Bosserman, Patrice Viens, Can Cai, Brian P. Mullaney, Ronald Peck, Gabriel N. Hortobágyi
Published 2007Artigo -
3
Effect of a Patient and Clinician Communication-Priming Intervention on Patient-Reported Goals-of-Care Discussions Between Patients With Serious Illness and Clinicians by J. Randall Curtis, Lois Downey, Anthony L. Back, Elizabeth L. Nielsen, Sudiptho R. Paul, Alexandria Z. Lahdya, Patsy D. Treece, Priscilla Armstrong, Ronald Peck, Ruth A. Engelberg
Published 2018Artigo -
4
Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, As First-Line Therapy in Patients With Metastatic Breast Cancer Previously Treated With Anthracycline C... by Henri Roché, Louise Yelle, Francesco Cognetti, L. Mauriac, Craig A. Bunnell, Joseph A. Sparano, Pierre Kerbrat, Jean‐Pierre Delord, Linda T. Vahdat, Ronald Peck, David Lebwohl, Rana Ezzeddine, Hervé Curé
Published 2007Artigo -
5
Phase I Study of the Novel Epothilone Analog Ixabepilone (BMS-247550) in Patients With Advanced Solid Tumors and Lymphomas by Carol Aghajanian, Howard A. Burris, Suzanne F. Jones, David R. Spriggs, Marvin B. Cohen, Ronald Peck, Paul Sabbatini, Martee L. Hensley, F. Anthony Greco, Jakob Dupont, Owen A. O’Connor
Published 2007Artigo -
6
Phase II Clinical Trial of the Epothilone B Analog, Ixabepilone, in Patients With Non–Small-Cell Lung Cancer Whose Tumors Have Failed First-Line Platinum-Based Chemotherapy by Johan Vansteenkiste, Primo N. Lara, Thierry Le Chevalier, Jean-Luc Breton, Philip Bonomi, Alan B. Sandler, Mark A. Socinski, Catherine Delbaldo, Brent McHenry, David Lebwohl, Ronald Peck, Martin J. Edelman
Published 2007Artigo -
7
Randomized Phase III Trial of Ixabepilone Plus Capecitabine Versus Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane by Joseph A. Sparano, Eduard Vrdoljak, O. Rixe, Binghe Xu, Alexey Manikhas, Carlos A. Medina, Susanne Crocamo Ventilari da Costa, Jungsil Ro, Gonzalo Rubio, M. Rondinón, G. Pérez Manga, Ronald Peck, Valerie Poulart, Pierfranco Conté
Published 2010Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Cancer
Breast cancer
Ixabepilone
Metastatic breast cancer
Oncology
Anthracycline
Gastroenterology
Surgery
Adverse effect
Chemotherapy
Clinical endpoint
Clinical trial
Taxane
Capecitabine
Colorectal cancer
Neutropenia
Phases of clinical research
Progressive disease
Randomized controlled trial
Regimen
myalgia
Antibody
Anxiety
Cancer immunotherapy
Carboplatin
Cisplatin
Combination therapy
Confidence interval